Nuance Medical recently announced the successful acquisition of BIOCORNEUM, a state-of-the-art silicone gel scar treatment brand, previously owned by Sientra. BIOCORNEUM is now a part of the Biodermis portfolio, Nuance Medical’s brand specializing in silicone scar management products. This strategic move enhances Biodermis’ commitment to providing top-tier skin care solutions to healthcare professionals and their patients.
- Featured products at the show include: Biodermis’ full line of advanced silicone scar recovery solutions, such as sheeting and gels, alongside the proprietary Pro-Sil® silicone stick—a convenient, on-the-go option for scar management. Also showcased is Epifoam®, the only sterilizable silicone-coated liposuction compression foam, designed to provide the ideal conditions for the highest level of patient and practitioner satisfaction.
- Recognized for over 30 years of innovation and effectiveness in scar management, Biodermis has been at the forefront of medical-grade silicone treatments for over three decades. Known for its dedication to quality and innovation, Biodermis is a trusted name among healthcare providers for effective, non-invasive scar management solutions.
- With the addition of BIOCORNEUM to Biodermis’ extensive line of scar management solutions, it ensures that the acclaimed properties of BIOCORNEUM will continue under a brand that profoundly understands the needs and expectations of healthcare professionals and their patients.
For further information on Biodermis, visit: https://www.biodermis.com/.